Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Darunavir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 952Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Prezista

    02 2Prezista

    03 6Prezista/Prezcobix/Rezolsta/Symtuza

    04 2Revenue share - Symtuza

    05 4Symtuza

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Prezista/Prezcobix/Rezolsta/Symtuza

    Darunavir

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Prezista/Prezcobix/Rezolsta/Symtuza

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Johnson & Johnson

    Darunavir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 2,184

    2019 Revenue in Millions : 2,110

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Symtuza

    Darunavir

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Symtuza

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Gilead

    Darunavir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 488

    2019 Revenue in Millions : 379

    Growth (%) : 29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Prezista/Prezcobix/Rezolsta/Symtuza

    Darunavir

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Prezista/Prezcobix/Rezolsta/Symtuza

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Johnson & Johnson

    Darunavir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 2,083

    2020 Revenue in Millions : 2,184

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Symtuza

    Darunavir

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Symtuza

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Gilead

    Darunavir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 531

    2020 Revenue in Millions : 488

    Growth (%) : 9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Revenue share - Symtuza

    Darunavir

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Revenue share - Symtuza

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Gilead

    Darunavir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 530

    2021 Revenue in Millions : 531

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Prezista/Prezcobix/Rezolsta/Symtuza

    Darunavir

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Prezista/Prezcobix/Rezolsta/Symtuza

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Johnson & Johnson

    Darunavir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 1,943

    2021 Revenue in Millions : 2,083

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Prezista/Prezcobix/Rezolsta/Symtuza

    Darunavir

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Prezista/Prezcobix/Rezolsta/Symtuza

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Johnson & Johnson

    Darunavir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2023 Revenue in Millions : 1,854

    2022 Revenue in Millions : 1,943

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Revenue share - Symtuza

    Darunavir

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Revenue share - Symtuza

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Gilead

    Darunavir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2023 Revenue in Millions : 529

    2022 Revenue in Millions : 530

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Prezista

    Darunavir

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Prezista

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Johnson & Johnson

    Darunavir

    Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

    Currency : USD

    2014 Revenue in Millions : 9.40%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Prezista

    Darunavir

    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Brand Name : Prezista

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed

    Johnson & Johnson

    Darunavir

    Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

    Currency : USD

    2015 Revenue in Millions : 1,831

    2014 Revenue in Millions : 1,810

    Growth (%) : -1%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF